7959
7959
Research Article
INTRODUCTION is reported that it can be used as a salad and cooked like soups. It is
used to treat burns earache, insect stings, inflammation, skin sores,
Diabetes is silent killer that kills one person every 10 seconds. India ulcers, pruritis (itching skin) eczema and abscesses, in treatment of
is having the highest number of diabetics in the world. It is a cardiovascular disorders, dysuria, haematuria, gonorrhoea,
multifactorial disease which is characterized by hyperglycemia, dysentery, sore nipples and ulcers of mouth. It is used as blood
lipoprotein abnormalities, raised basal metabolic rate, defect in purifier. Roasted seeds are reported to be diuretic and anti-
reactive oxygen species scavenging enzymes and high oxidative dysenteric. Omega 3– fatty acids [9] present are used in the
stress induced damage to pancreatic beta cells It is associated with production of compounds that effect blood pressure clotting, the
long term complications, including retinopathy, nephropathy, immune system, lower cholesterol (LDL) and prevent certain
neuropathy and angiopathy and several others[1]. People with cancers and control coronary spasms. They have positive effect on
diabetes are 2-4 times more likely to develop heart diseases[2]. brain and in such conditions as depression, bipolar disorder,
Efforts are ongoing to understand and manage diabetes mellitus Alzhemiers disease, schizophrenia, hyperactivity and migrane.
because the disease and disease related complications are increasing Reported Pharmacological Activities include antifungal[10],
day by day. In spite of presence of large number of medicines in the antibacterial[11], analgesic, anti-inflammatory [12][13], gastric
pharmaceutical market, remedies from medicinal plants are used antiulcerogenic [14], bronchodilatory [15], skeletal muscle relaxant
with success to treat this disease. There has been great demand for [16],antihypertensive [17], neuropharmacological [18], wound
plant products due to low cost, easy availability and lesser side healing [19], antioxidant [20], antifertility [21] and antitumour
effects. For this plant materials are continuously scrutinized and activities [22].Therefore, with reference to traditional and reported
explored for their effect as antidiabetic and hypoglycaemic activity. uses, the present study was undertaken to investigate the
The acute oral toxicity test aims at establishing the therapeutic index, hypoglycaemic activity of this plant and give a scientific rational for
i.e. the ratio between the pharmacologically effective dose and the its use.
lethal dose on the same strain and species (LD50/ED50). The
greater the index the safer the compound and vice versa. However, MATERIALS AND METHODS
the term acute oral toxicity is most often used in connection to
lethality and LD determinations [3][4]. The evaluation of the toxic Plant Material
action of the plant extracts is important in order to consider a The whole plant of Portulaca oleracea (Family Portulacaceae ) were
treatment safe. collected from Nishat area of the district, Srinagar, during the
Portulaca oleracea, belonging to Family Portulacaceae (Purslane months of April to June and authenticated by a plant taxonomist in
family) is commonly called as Common Purslane in English, as Kurfa the Centre of Plant Taxonomy, University of Kashmir, Srinagar. The
in Mumbai, as Loni, Ghol in Gujrati, as Kursa, Chhota Lunia in identification was done on the basis of the characters described by
Hindi,as Lonak in Punjabi and as Nunar in Kashmiri. It is a Kirtikar and Basu, 1935. A sample of the plant material was
cosmopolitan weed in warm temperate, tropical and subtropical deposited in the herbarium of the Department of Taxonomy,
regions of the world[5][6]. In Srinagar it grows along waste lands University of Kashmir under voucher specimen number
and in cultivated gardens. It contains carboxylic acids, some gums, 1011(KASH) dated 15-09-2008 for future reference. The plant
fatty acids[7] beta-carotene and volatile oil and Portuloside A, a material was dried in a well ventilated room with outside
monoterpene glucoside and phenolic alkaloids[8]. In folk medicine it temperature ranging between 18 to 320 C.
Sabeeha et al.
Int J Pharm Pharm Sci, Vol 5, Suppl 4, 389-393
The extract obtained was subjected to qualitative tests for Group III PO (400 mg/kg b.w)
identification of different constituents like tannins, alkaloids, The treatment was continued for 14 days. During this period, mice of
saponins, glycosides, terpenes, phenolics, flavonoids, carbohydrates, Normal Control group received only 2% gum acacia.
proteins and steroids, by using simple and standard qualitative
methods. [23][24][25]. Assessment of hypoglycaemic activity
Pharmacological Study[26][27]28] After 14 days of treatment, the mice were fasted overnight and on
the 15th day the mice were anaethesized with diethyl ether and
Animals and Exposure conditions blood sample from each animal was collected by cardiac puncture, in
Swiss albino mice weighing about 20-25 gm were taken for sterilized centrifuge tubes. The blood samples were allowed to
conducting acute oral toxicity study and for hypoglycaemic activity. coagulate at 30oC. Serum was separated by centrifugation at 2500
The animals were procured from Central Animal House, IIIM (Indian r/min at 30oC for 15 min and subjected to biochemical investigation
Institute of Integrative Medicine) Jammu & were housed in clean using standard test kit to assess serum glucose level [29][30].
polypropylene cages. Before initiation of experiment, the mice were Glucose kit was obtained from Crest Biosystems, Goa, India.
acclimatized for a period of 7 days. Standard environmental Statistical analysis
conditions such as temperature ranging from 18 to 32o C, relative
humidity (70%) and 12 hrs dark/light cycle were maintained in the All the results were expressed as mean ± SEM. One way analysis of
quarantine. All the animals were fed with rodent pellet diet variance (ANOVA) was used for the statistical analysis of data.
(Ashirwad Industries) and water ad-libitum under strict hygienic Students “t” test was used for determining the significance. A
conditions. All procedures were performed in accordance to CPCSEA probability value of p > 0.05 was considered as non significant, *p<
guidelines after approval from the Institutional Animal and Ethics 0.05 – significant, **p< 0.01- highly significant and ***p<0.001 as
Committee (IAEC) of the Department of Pharmaceutical Sciences, very highly significant.
University of Kashmir [No. F-IAEC (Pharm.Sc) APPROVAL / 2008/ 4
RESULTS
Dated Oct 23rd, 2008].
Phytochemical screening (Table 1)
Acute Oral Toxicity study
The phytochemical screening of 50% ethanolic extract of Portulaca
50% ethanolic extract of Portulaca oleracea (whole plant) (PO)
oleracea (PO) carried out by standard procedures revealed the
was screened for acute oral toxicity study. The animals were
presence of tannins, alkaloids, saponins, glycosides, terpenes,
distributed into five groups. Group I, II, III, IV and V.
phenolics, flavonoids, carbohydrates, proteins and steroids.
Group I served as Normal Control and received 2% gum acacia.
The results obtained were comparable and satisfied the standard
Group II received 500 mg/kg b.w (PO), literature.
Group III received 1000 mg/kg b.w (PO) Table 1: Results of Phytochemical screening of Portulaca
oleracea (whole plant)
Group IV received 1500 mg/kg b.w (PO)
Phytoconstituents Results
Group V received 2000 mg/kg b.w (PO). 1 Tannins +
All extracts were given in 2% gum acacia. After the extract 2 Alkaloids +
administration, food was withheld for 2 hours. The extracts were 3 Saponins +
administered in a single dose by using specially designed mice oral 4 Glycosides +
feeding needle. The observations that were recorded during 72 5 Terpenes +
hours were grooming, hyperactivity, sedation, respiratory arrest, 6 Phenolics +
convulsions, increased and decreased motor activity and mortality if 7 Flavonoids +
any. 8 Carbohydrates +
9 Proteins +
Observations made during acute oral toxicity studies 10 Steroids +
Grooming- Clearing the fur and skin of itself or another animal
Acute Oral Toxicity Tests ( 72 hour study) (Table 2)
Hyperactivity- Abnormality and excessive activity; unable to relax
Portulaca oleracea administered at four dose levels (500, 1000,
Sedation- Calm and composed animals without any stress 1500 and 2000 mg/kg b.w) revealed the following effects during the
Respiratory arrest- Rising of head acute toxicity studies conducted in mice for 72 hours. Control mice
which had received 2% of gum acacia showed normal behaviour
Convulsions- Tremor in the tail or paddling of the feet
i) Grooming: After, 48 and 72 hours, no grooming was observed
Increased motor activity at all the four dose levels.
Decreased motor activity ii) Hyperactivity: PO extract at the administered dose levels had
Mortality. no effect on the activity of mice which remained normal.
390
Sabeeha et al.
Int J Pharm Pharm Sci, Vol 5, Suppl 4, 389-393
iii) Sedation: After 48 hours, sedation was seen in 50 % of animals v) Convulsions: After 48 and 72 hours 50 % of animals in the
at the dose of 500 mg/kg b.w while 100 % of animals in the dose range of 500 mg/kg b.w and 100% animals in the dose
dose range of 1000, 1500 and 2000 mg/kg b.w showed range of 1000,1500 and 2000 mg/kg b.w showed convulsions
sedation,as the animals remained calm and composed without as tremor in the tail and the paddling of the feet.
any stress. vi) Motor Activity: After 48 hours, 50 % of animals at the dose of 500
mg/kg b.w and. 100 % of animals in the dose range of 1000,1500
iv) Respiratory arrest: After 48 hours, 50 % of animals in the
and 2000 mg/kg b.w showed decreased motor activity.
dose range of 500 mg/kg b.w and 100% animals in the dose
range of 1000, 1500 and 2000 mg/kg b.w showed respiratory vii) Mortality: 50 % of animals died at the dose of 500 mg/kg b.w
arrest indicated by raising of head in both animals of these after 72 hours while 100 % of animals in the dose range of
groups. 1000, 1500 and 2000 mg/kg b.w died after 24 hours.
Table 2: Observations during acute toxicity studies of different doses of 50% Ethanolic extract of Portulaca oleracea (whole plant)
S. No. Treatment Observations (Hours)
Grooming Hyperactivity
1 2 3 4 24 48 72 1 2 3 4 24 48 72
1 Normal control + + + + + + + - - - - - - -
2% aqueous gum acacia
2 + + + + + + + - - - - - - -
1 500 mg/kg b.w + + + + - - - - - - - - -
2 + + + + - - - - - - - -
1 1000mg/kg b.w + + + + - - - - - -
2 + + + + - - - - - -
1 1500mg/kg b.w + + + - - - - - - -
2 + + + - - - - - - -
1 2000mg/kg b.w + + + - - - - - - -
2 + + + - - - - - - -
S. No Treatment Observation (Hours)
Sedation Respiratory Arrest
1 2 3 4 24 48 72 1 2 3 4 24 48 72
1 Normal control - - - - - - - - - - - - - -
2% aqueous gum acacia
2 - - - - - - - - - - - - - -
1 500mg/kg b.w - - - - - - - - - - - _ -
2 - - - - + - - - - + -
1 1000mg/kg b.w - - - + + - - - - + -
2 - - - + + - - - - + -
1 1500mg/kg b.w - - - + + - - - - + -
2 - - - + + - - - - + -
1 2000mg/kg b.w - - - + + - - - - + -
2 - - - + + - - - - + -
S. No Treatment Observations (Hours)
Convulsions Increased motor activity
1 2 3 4 24 48 72 1 2 3 4 24 48 72
1 Normal control - - - - - - - - - - - - - -
2% aqueous gum acacia
2 - - - - - - - - - - - - - -
1 500mg/kg b.w - - - - - - - - - - - -
2 - - - - + - - - - - -
1 1000mg/kg b.w - - - - + - - - - -
2 - - - - + - - - - -
1 1500mg/kg b.w - - - + + - - - - -
2 - - - + + - - - - -
1 2000mg/kg b.w - - - + + - - - - -
2 - - - + + - - - - -
S. No Treatment Observation (Hours)
Decreased Motor Activity Death
1 2 3 4 24 48 72 1 2 3 4 24 48 72
1 Normal control - - - - - - - - - - - - - -
2% aqueous gum acacia
2 - - - - - - - - - - - - - -
1 500mg/kg b.w - - - - - - - - - - - - -
2 - - - - + - - - - - - Dead
1 1000mg/kg b.w - - - - + - - - - Dead
2 - - - - + - - - - Dead
1 1500mg/kg b.w - - - + + - - - - Dead
2 - - - + + - - - - Dead
1 2000mg/kg b.w - - - + + - - - - Dead
2 - - - + + - - - - Dead
391
Sabeeha et al.
Int J Pharm Pharm Sci, Vol 5, Suppl 4, 389-393
Table 3: Results of hypoglycaemic activity of different doses of 50% ethanolic extract of Portulaca oleracea (whole plant)
Group Treatment Serum Glucose Levels (mg/dl)
I Normal Control 91.50± 6.80
II PO 200 mg/kg 60.00± 9.83*
III PO 400 mg/kg 46.83± 5.84**
The observations are mean ± SEM of 6 animals,*p<0.05 and **p<0.01 as compared to that of Normal Control group (One way ANOVA followed by
students “t “test).
*p < 0.05 – Significant, **p < 0.01 – Highly Significant
DISCUSSION ACKNOWLEDGEMENT
Diabetes mellitus is a metabolic disorder characterized by resistance We are highly thankful to University Grants Commission, New Delhi
in the action of insulin, insufficient insulin secretion or both. It is for financial assistance. The facilities provided by the Department of
becoming one of the most common diseases of the world. Type II Pharmaceutical Sciences University of Kashmir for carrying out this
diabetes in young has increased 30 fold over the last 20 years work also need appreciation.
concomitant with increase in obesity. Studies have revealed that all
incidences of diabetes in this young age group is 2.5% and REFERENCES
alarmingly 25% of their young adults have abnormalities of blood 1. Alberti KG, Zimmet PZ. Definition diagnosis and classification of
glucose. Today in India alone there are more than 4.00 crore diabetes mellitus and its complications. Part I: Diagnosis and
diabetics and the number is going to be around 9.00 crore by 2030. classification of diabetes mellitus, provisional report of a WHO
Over 7.20 lakh Indians die every year due to diabetes. India has consultation. Diabetes Med. 1998; 15: 539-553.
45,000 plant species and several thousand have medicinal 2. Adler AL, Stration IM, Neil HA. Association of systolic blood
properties. More than 800-1000 plant species have anti- diabetic pressure with macrovascular and macrovascular complications
activity. Herbal medicines have received greater attention as an of type 2 diabetes (UKPDS 36). Prospective observational study
alternative to clinical therapy and the demand for these remedies British Medical Journal. 2000; 321 (7258): 412-419.
has currently increased. 3. Ghosh MN. Fundamentals of experimental Pharmacology 2nd
The Indian indigenous drugs have great importance both from Edition, Scientific Book Agency Calcutta. 1984; 154-157.
professional and economic point of view[31-40]. A large number of 4. Ghosh MN. Fundamentals of Experimental Pharmacology, 3rd
plants have been reported to possess anti-diabetic activity e.g., Edition. S.K. Ghosh & others publications. 2005; 190-197.
Aconitum napeilus, Aloe vera, Carum carvi, Cichorium intybus, Allium 5. Banerjee, Gautam and Mukherjee. Portulaca oleracea L: A gem
cepa, Aralia cachemirica, Allium sativum, Momordia charantia..An of aliens in India. J of Phytochem Res. 1996; 9(2): 111-115.
acute toxicity test can give details about the biologic properties and 6. Mitish, Larry W. Common purslane (Portulaca oleracea). Weed
the mechanism of action of a chemical compound than any other Technology. 1997;11(2): 394-397
single test. Long-term studies usually start with a dose finding 7. Liu L. Fatty acids and ß carotene in Australian Purslane
exercise under acute conditions. The importance of this plant in folk (Portulaca oleracea) varieties. J Chromatogr. 2000; 893: 207-
medicine as well as promoting pharmacological properties, make 213.
studies about its toxicity very important. 8. Zijuan Y, Cejia L, Lan X, Yinan Z. Phenolic alkaloids as a new
class of antioxidants in Portulaca oleracea, Phytotherapy Res.
The phytochemical screening of 50% ethanolic extract of whole 2009; 23(7): 1032-1035.
plant of Portulaca oleracea carried out by standard procedures 9. Simopoulos AP, Norman HA, Gillaspy JE, Duke JA. Common
revealed the presence of alkaloids, flavonoids, glycosides, terpenes, Purslane: a source of omega-3 fatty acids and anti-oxidants. J
saponins, carbohydrates, proteins, tannins, phenolics and steroids. Amer College Nutr. 1992; 11 (4): 374-382.
10. Banerjee G, Mukherjee A. Biological activity of a common weed:
The oral administration of 50% ethanolic extract of whole plant in Portulaca oleracea L.-II. Antifungal activity. Acta Botan
doses of 500-2000 mg/kg b.w showed that 50% of animals died in Hungarica. 2002; 44(3-4): 205-08.
the dose range of 500 mg/kg b.w and 100 % of animals died in the 11. Banerjee G, Mukherjee A. Antibacterial activity of a common
dose range of 1000, 1500 and 2000 mg/kg b.w. w after 72 hours. weed, Portulaca oleracea. L. Geobios (Jowhpur). 2003; 30(2-3):
The behavioural observations showed that there was effect on 143-144.
grooming, sedation, respiratory arrest, convulsions. There was 12. Chan.K, Islam MW, Kamil M, Radhakrishan R, Zakaria MNM.
decreased motor activity before death. It can be concluded that The analgesic and anti-inflammatory effects of Portulaca
LD50 of the plant is 500mg/kg b.w which means that doses below oleracea L., sub sp. Sativa. J of Ethnopharmacol. 2000; 73( 3):
500 mg/kg b.w are safe for oral administration. Since LD50 of the 445-451.
ethanolic extract was 500mg/kg b.w, so the present studies were 13. Islam MW, Zakaria MNM, Radhakrishan R. Evaluation of
carried at the dose levels of 200 and 400 mg/kg b.w/day of the 50% analgesic activity of the aerial parts of Portulaca oleracea v.
ethanolic extract of the plant. sativa and its comparison with two related spices. J of Pharm
and Pharmacol. 1998; 50: 226-230
In hypoglycaemic study, the 50 % ethanolic extract of the whole 14. Karimi G, Hosseinzadeh H, Ettehad N.Evaluation of the gastric
plant when administered for 14 days showed reduction in serum antiulcerogenic effects of Portulaca oleracea L. extracts in mice.
glucose levels. The dose of 400mg/kg was found to be more Phytother Res. 2004; 18(6): 484-487.
effective. This shows that Portulaca oleracea has significant 15. Malek F, Oskabady MH, Borushaki MT, Tohidi M.
hypoglycemic effect. The literature and the studies reveal that Bronchodilatory effect of Portulaca oleracea in airways of
flavonoids and tannins present in the plant extract might be asthmatic patients. J Ethnopharmacol. 2004; 93(1): 57-62.
responsible for showing this activity. 16. Okwuasaba FC, Ejibe, Parry O. Skeletal muscle relaxant
CONCLUSION properties of the aqueous extract of the Portulaca oleracea. J
Ethnopharmacol. 1986; 17: 139-160.
From the study, it can be concluded that the 50% ethanolic extract of 17. Parry O, Okwuasaba F, Ejibe C. Effect of an aqueous extract of
whole plant of Portulaca oleracea has beneficial effects on serum Portulaca oleracea leaves on smooth muscle and rat blood
glucose levels by showing hypoglycaemic activity. Further pressure. J Ethnopharmacol. 1988; 22: 33-44.
pharmacological and biochemical investigations will clearly 18. Radhakrishan, R, Zakaria MNM, Islam MW, Ismail A, Habibullah
elucidate the mechanism of action and will be helpful in projecting M, Chan K. Neuropharmacological actions of Portulaca oleracea
this plant as an therapeutic target in diabetics research. v. sativa. J of Pharm and Pharmacol. 1998;50: 225.
392
Sabeeha et al.
Int J Pharm Pharm Sci, Vol 5, Suppl 4, 389-393
19. Rashed AN, Afifi FU and Disi AM. Simple evaluation of the the OECD guidelines for the testing of chemicals organization
wound healing activity of a crude extract of Portulaca oleracea for economical co-operation and development. Paris, June,
L. in Mus musculus JVI-1. J Ethnopharmacol. 2003;88(2-3): 2002.
131-136. 29. Trinder P. Determination of Glucose in Blood Using Glucose
20. Sanja SD, Sheth NR, Patel NK. Characterization and evaluation Oxidase with an Alternative Oxygen Acceptor. Ann Clin
of anti-oxidant activity of Portulaca oleracea. Inter J of Pharm Biochem. 1966;6: 24-25
and Pharmaceutical Sci. 2009; 1( 1):74-84 30. Trinder P. Glucose oxidase method. Ann Clin Biochem. 1969; 6.
21. Verma OP, Kumar S, Chatterjee SN. Anti-fertility effects of 31. Grover JK, Yadav S and Vats. Medicinal Plants of India with
common edible Portulaca oleracea on the reproductive organs anti-diabetic potential. J Ethnopharmacol. 2002; 81: 81-100.
of male albino mice. Ind J of Med Res. 1982;75: 301-310. 32. Rafiullah MRM, Siddiqui AW, Mir SR, Ali M, Pillai KK, Singh S.
22. Yoon JW, Ham SS, Jun HS. Portulaca oleracea and tumour cell Antidiabetic Activity of some Indian Medicinal Plants. 2006;
growth. Official Gazette of the United States Patent and 44(2):95-99
Trademark Office Patents. 1999; 1219(2): 1472. 33. Kirtikar and Basu. Indian Medicinal Plants. Dehra Dun,
23. Harborne JB Phytochemical methods. Chapman and Hall Ltd., Uttaranchal, India. 2001; 2: 333-335.
London. 1973; 49-188. 34. Kirtikar KR, Basu BD Indian Medicinal Plants. 2nd ed. Lalit
24. Rafia Rasool, Bashir A Ganai, Seema Akbar, Azra Kamili. Phyto Mohan Basu, Allahabad. 1933; 1478-81.
chemical screening of Prunella vulgaris L.An important 35. Kirtikar KR, Basu BD Illustrated Indian Medicinal Plants, India
Medicinal Plant of Kashmir Pak. J. Pharm Sci. 2010; 23(4): 399- Sri Satguru Publications, Delhi. 2000a; 2: 330-333.
402. 36. Kirtikar KR, Basu BD Illustrated Indian Medicinal Plants, India,
25. Trease GE and Evans WC. Pharmacognosy, 11th edn., Brailliar Sri Satguru Publications, Delhi. 2000b;7: 2241.
Tiridel Can., Macmillian Publishers;1989. 37. Rastogi RP, Mehrotra BN Compendium of Indian Medicinal
26. Babu V, Gangadevi T, Subramanian A Antidiabetic activity of Plants Publications and Information’s Directorate (CSIR), New
ethanol extract of Cassia Klenii leaf in streptozotocin-induced Delhi. 1999; Vol I:pp 326, 398.
diabetic rats and isolation of an active fraction and toxicity 38. Rastogi RP, Mehrotra BN. Compendium of India Medicinal
evaluation of the extract. Ind. J of Pharmacol. 2003; 35: 290- Plants Publications and Information Directorate (CSIR), New
296. Delhi. 1990; Vol II: 398.
27. OECD. Guidance document on the recognition, assessment and 39. Rastogi RP, Mehrotra BN Compendium of Indian Medicinal
use of clinical signs as human endpoints for experimental Plants Publications and Information Directorate (CSIR), New
animals used in safety evaluation. Series on Testing and Delhi. 1991; Vol II: 660.
Assessment No. 19. ENV/ JM/MOMO; 2000: 7. 40. Rastogi RP, Mehrotra BN. Compendium of Indian Medicinal
28. OECD. Acute oral toxicity. Acute and toxic class method Plants India Publications and Information Directorate (CSIR),
guideline, 423 adopted 23.03.1996. In: Eleventh Addendum to New Delhi. 1995; Vol V: 405.
393